Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RIOCIGUAT
- Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets
- Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
- Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
- Effect of Riocigaut on Migraine Attack Induction and Cerebral Vasodilation in Migraine Patients.
- Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy Volunteers
- Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH
- Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH
- Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH
- Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)
- Initial Dual Oral Combination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
- Study of Possible Effects of the Drugs Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers
- THERAPY-HYBRID-BPA Trial
- A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
- A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
- Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
- Upfront Combination Pulmonary Arterial Hypertension Therapy
- Treatment of Exercise-Induced Pulmonary Vascular Dysfunction in Symptomatic Patients After Pulmonary Thromboendarterectomy
- Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics
- Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)
- Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension
- Riociguat in Scleroderma Associated Digital Ulcers
- Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.
- Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
- Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension
- A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases
- Riociguat for Sarcoidosis Associated Pulmonary Hypertension
- Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
- Interaction With HIV Antiretroviral Agents
- Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)
- Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
- Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
- Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women
- Relative Bioavailability Study
- Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
- Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )
- EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
- Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude
- Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
- Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
- Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Relative Bioavailability and Food Effect Study
- Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters.
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
- Coronary Vasomotor Response After Riociguat Exposure
- A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
- Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics
- Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation
- Effect of Riociguat on Bone Metabolism
Clinical trials list
click for details